nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—ADRA2C—attention deficit hyperactivity disorder	0.588	0.701	CbGaD
Levonordefrin—ADRA2A—attention deficit hyperactivity disorder	0.251	0.299	CbGaD
Levonordefrin—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0102	0.346	CbGeAlD
Levonordefrin—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00542	0.184	CbGeAlD
Levonordefrin—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00126	0.0428	CbGeAlD
Levonordefrin—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00117	0.0398	CbGeAlD
Levonordefrin—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000993	0.0337	CbGeAlD
Levonordefrin—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000893	0.0303	CbGeAlD
Levonordefrin—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000739	0.0251	CbGeAlD
Levonordefrin—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000686	0.0233	CbGeAlD
Levonordefrin—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000661	0.0224	CbGeAlD
Levonordefrin—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000638	0.0216	CbGeAlD
Levonordefrin—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000614	0.0208	CbGeAlD
Levonordefrin—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000608	0.0206	CbGeAlD
Levonordefrin—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.0006	0.0203	CbGeAlD
Levonordefrin—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.00059	0.02	CbGeAlD
Levonordefrin—Methyldopa—COMT—attention deficit hyperactivity disorder	0.000585	0.0773	CrCbGaD
Levonordefrin—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000585	0.0198	CbGeAlD
Levonordefrin—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000572	0.0194	CbGeAlD
Levonordefrin—Droxidopa—ADRA2C—attention deficit hyperactivity disorder	0.000546	0.072	CrCbGaD
Levonordefrin—SLC6A2—brain—attention deficit hyperactivity disorder	0.000524	0.0178	CbGeAlD
Levonordefrin—ADRA1A—brain—attention deficit hyperactivity disorder	0.000487	0.0165	CbGeAlD
Levonordefrin—L-DOPA—DRD5—attention deficit hyperactivity disorder	0.000487	0.0643	CrCbGaD
Levonordefrin—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000485	0.0164	CbGeAlD
Levonordefrin—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000467	0.0158	CbGeAlD
Levonordefrin—ADRA2C—brain—attention deficit hyperactivity disorder	0.000465	0.0157	CbGeAlD
Levonordefrin—Norepinephrine—ADRA2C—attention deficit hyperactivity disorder	0.000459	0.0606	CrCbGaD
Levonordefrin—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000456	0.0155	CbGeAlD
Levonordefrin—Dopamine—DRD5—attention deficit hyperactivity disorder	0.000453	0.0598	CrCbGaD
Levonordefrin—Epinephrine—ADRA2C—attention deficit hyperactivity disorder	0.000417	0.055	CrCbGaD
Levonordefrin—Methyldopa—ADRA2A—attention deficit hyperactivity disorder	0.000373	0.0492	CrCbGaD
Levonordefrin—ADRA2A—brain—attention deficit hyperactivity disorder	0.000371	0.0126	CbGeAlD
Levonordefrin—Phenylpropanolamine—MAOA—attention deficit hyperactivity disorder	0.0003	0.0396	CrCbGaD
Levonordefrin—Dopamine—COMT—attention deficit hyperactivity disorder	0.000286	0.0377	CrCbGaD
Levonordefrin—Phenylpropanolamine—DRD1—attention deficit hyperactivity disorder	0.000273	0.036	CrCbGaD
Levonordefrin—Phenylpropanolamine—SLC6A3—attention deficit hyperactivity disorder	0.000259	0.0341	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRA2A—attention deficit hyperactivity disorder	0.000254	0.0335	CrCbGaD
Levonordefrin—L-DOPA—DRD4—attention deficit hyperactivity disorder	0.000249	0.0329	CrCbGaD
Levonordefrin—Droxidopa—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.0307	CrCbGaD
Levonordefrin—Dopamine—DRD4—attention deficit hyperactivity disorder	0.000232	0.0306	CrCbGaD
Levonordefrin—Dopamine—MAOA—attention deficit hyperactivity disorder	0.000216	0.0285	CrCbGaD
Levonordefrin—L-DOPA—DRD3—attention deficit hyperactivity disorder	0.000215	0.0284	CrCbGaD
Levonordefrin—L-DOPA—DRD1—attention deficit hyperactivity disorder	0.000211	0.0278	CrCbGaD
Levonordefrin—Dopamine—DRD3—attention deficit hyperactivity disorder	0.0002	0.0264	CrCbGaD
Levonordefrin—Dopamine—DRD1—attention deficit hyperactivity disorder	0.000196	0.0259	CrCbGaD
Levonordefrin—Norepinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000196	0.0259	CrCbGaD
Levonordefrin—Dopamine—SLC6A3—attention deficit hyperactivity disorder	0.000186	0.0245	CrCbGaD
Levonordefrin—Epinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.0235	CrCbGaD
Levonordefrin—L-DOPA—DRD2—attention deficit hyperactivity disorder	0.000149	0.0196	CrCbGaD
Levonordefrin—Norepinephrine—DRD2—attention deficit hyperactivity disorder	0.000149	0.0196	CrCbGaD
Levonordefrin—Dopamine—SLC6A4—attention deficit hyperactivity disorder	0.000139	0.0183	CrCbGaD
Levonordefrin—Dopamine—DRD2—attention deficit hyperactivity disorder	0.000138	0.0182	CrCbGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000117	0.000943	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000115	0.000926	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000115	0.000926	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000114	0.000918	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000113	0.00091	CbGpPWpGaD
Levonordefrin—ADRA2C—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000112	0.000902	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000112	0.0009	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000111	0.000899	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000111	0.000899	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000111	0.000898	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000111	0.000896	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000109	0.000881	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000109	0.000881	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000109	0.000877	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000107	0.000865	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000105	0.000849	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000104	0.000837	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000104	0.000835	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000103	0.000835	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000834	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000103	0.000832	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000102	0.000824	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000102	0.000821	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.000821	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000101	0.000819	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000101	0.000818	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0001	0.00081	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0001	0.000809	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	9.86e-05	0.000795	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.83e-05	0.000793	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	9.75e-05	0.000786	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.74e-05	0.000785	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.66e-05	0.000779	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	9.62e-05	0.000776	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	9.58e-05	0.000773	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	9.54e-05	0.00077	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.54e-05	0.00077	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	9.52e-05	0.000768	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.51e-05	0.000767	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	9.37e-05	0.000756	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	9.32e-05	0.000752	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	9.08e-05	0.000733	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	9.07e-05	0.000732	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.05e-05	0.00073	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.9e-05	0.000718	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.89e-05	0.000717	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.87e-05	0.000716	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	8.87e-05	0.000715	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	8.7e-05	0.000702	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.59e-05	0.000693	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.47e-05	0.000684	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.45e-05	0.000681	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	8.43e-05	0.00068	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.34e-05	0.000673	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.31e-05	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.31e-05	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.3e-05	0.00067	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.27e-05	0.000667	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.24e-05	0.000665	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	8.22e-05	0.000663	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.01e-05	0.000646	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	7.98e-05	0.000644	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.88e-05	0.000635	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.78e-05	0.000628	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.78e-05	0.000628	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.77e-05	0.000627	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.75e-05	0.000626	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.75e-05	0.000625	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.73e-05	0.000623	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.72e-05	0.000623	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.69e-05	0.000621	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.54e-05	0.000608	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.48e-05	0.000604	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.36e-05	0.000594	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	7.35e-05	0.000593	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.27e-05	0.000586	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.27e-05	0.000586	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.27e-05	0.000586	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.25e-05	0.000585	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.22e-05	0.000582	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	7.04e-05	0.000568	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.04e-05	0.000568	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.92e-05	0.000558	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.8e-05	0.000549	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.78e-05	0.000547	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.78e-05	0.000547	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.77e-05	0.000546	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.76e-05	0.000545	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.75e-05	0.000545	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.66e-05	0.000538	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	6.58e-05	0.000531	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.54e-05	0.000528	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.43e-05	0.000519	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.43e-05	0.000519	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.35e-05	0.000512	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.35e-05	0.000512	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.33e-05	0.000511	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.3e-05	0.000508	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.28e-05	0.000507	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.28e-05	0.000506	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.23e-05	0.000502	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.16e-05	0.000497	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.08e-05	0.00049	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.92e-05	0.000477	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.9e-05	0.000476	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.9e-05	0.000476	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.84e-05	0.000471	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.75e-05	0.000464	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.72e-05	0.000461	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.53e-05	0.000446	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.5e-05	0.000444	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.44e-05	0.000439	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.37e-05	0.000434	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.29e-05	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.22e-05	0.000422	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.14e-05	0.000415	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.07e-05	0.000409	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.06e-05	0.000408	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.03e-05	0.000406	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.94e-05	0.000399	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.88e-05	0.000394	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.74e-05	0.000382	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.7e-05	0.000379	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.7e-05	0.000379	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.68e-05	0.000377	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.57e-05	0.000368	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.54e-05	0.000367	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.53e-05	0.000365	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.45e-05	0.000359	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.45e-05	0.000359	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.4e-05	0.000355	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.37e-05	0.000352	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.37e-05	0.000352	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.37e-05	0.000352	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.32e-05	0.000349	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.27e-05	0.000344	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.27e-05	0.000344	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.25e-05	0.000343	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.23e-05	0.000341	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.16e-05	0.000336	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.16e-05	0.000335	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.14e-05	0.000334	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.12e-05	0.000333	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.11e-05	0.000332	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.11e-05	0.000331	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.11e-05	0.000331	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.09e-05	0.00033	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.08e-05	0.000329	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.04e-05	0.000326	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.01e-05	0.000324	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.99e-05	0.000322	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.97e-05	0.00032	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.96e-05	0.00032	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.85e-05	0.000311	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.84e-05	0.00031	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.82e-05	0.000309	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.82e-05	0.000308	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.82e-05	0.000308	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.78e-05	0.000305	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.73e-05	0.000301	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.73e-05	0.000301	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.72e-05	0.0003	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.71e-05	0.000299	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.7e-05	0.000298	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.64e-05	0.000293	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.63e-05	0.000293	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.59e-05	0.00029	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.57e-05	0.000288	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.55e-05	0.000286	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.5e-05	0.000283	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	3.5e-05	0.000283	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.47e-05	0.00028	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.47e-05	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.46e-05	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.45e-05	0.000278	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	3.45e-05	0.000278	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.44e-05	0.000277	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.38e-05	0.000273	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.36e-05	0.000271	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.34e-05	0.00027	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.34e-05	0.000269	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.31e-05	0.000267	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.3e-05	0.000266	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.26e-05	0.000263	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.22e-05	0.00026	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.21e-05	0.000259	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.12e-05	0.000252	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.11e-05	0.000251	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.09e-05	0.000249	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.04e-05	0.000245	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.03e-05	0.000244	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.88e-05	0.000233	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.87e-05	0.000231	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.85e-05	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.85e-05	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.82e-05	0.000228	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.8e-05	0.000226	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.8e-05	0.000226	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.7e-05	0.000218	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.68e-05	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.67e-05	0.000215	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.6e-05	0.00021	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.6e-05	0.00021	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.52e-05	0.000203	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.52e-05	0.000203	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.51e-05	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.43e-05	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.43e-05	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	2.4e-05	0.000194	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.39e-05	0.000193	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.36e-05	0.00019	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.34e-05	0.000189	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.34e-05	0.000189	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.34e-05	0.000189	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.28e-05	0.000184	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.27e-05	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	2.25e-05	0.000181	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.23e-05	0.00018	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.2e-05	0.000178	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.2e-05	0.000178	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.2e-05	0.000177	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.18e-05	0.000176	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.13e-05	0.000172	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	2.12e-05	0.000171	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	2.11e-05	0.00017	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.05e-05	0.000166	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.05e-05	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.05e-05	0.000165	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.98e-05	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.98e-05	0.000159	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.95e-05	0.000157	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.93e-05	0.000155	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.9e-05	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.84e-05	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.82e-05	0.000147	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.79e-05	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.79e-05	0.000144	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.72e-05	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.71e-05	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.67e-05	0.000134	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.54e-05	0.000124	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.44e-05	0.000116	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.26e-05	0.000101	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.17e-05	9.42e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	9.11e-06	7.35e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.15e-06	6.58e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.61e-06	6.14e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	7.4e-06	5.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.66e-06	5.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.18e-06	4.99e-05	CbGpPWpGaD
